罗氟司特在哪里买比较靠谱？

Deroflumilast is a drug used to treat chronic obstructive pulmonary disease (COPD) that inhibits the production of pro-inflammatory mediators. This article will introduce in detail the purchase channels, listing status and price of deuteroflumilast. By knowing this information, patients can better plan how to obtain and use this medication.

Where to buy deuteroflumilast more reliably

The purchasing channels vary from region to region. The following are some common purchasing methods.

Hospital Pharmacy

In many countries and regions, deroflumilast can be purchased through hospital pharmacies. Patients need a doctor's prescription to purchase the drug at the hospital pharmacy. Hospital pharmacies can usually provide drugs from formal channels and ensure the quality of drugs.

Online pharmacies

Some online pharmacies also provide deuteroflumilast sales services. Patients can purchase drugs through legitimate online pharmacies to avoid purchasing fake and shoddy drugs. When purchasing online, patients should provide a valid prescription.

Medical service institutions

For areas where deroflumilast is not yet on the market, patients can obtain the drug through regular domestic medical service institutions. After placing an order, the patient can obtain the drug by mail.

Understanding the purchasing channels of deroflumilast can help patients choose the most appropriate method of acquisition according to their own circumstances. Regardless of which option you choose, patients should ensure that their medications come from legitimate sources and avoid using uncertified medicines.

Roflumilast's marketing status

Roflumilast has been approved for marketing in many countries and regions around the world, but it is still not available in some regions. The following is the marketing status of roflumilast in different regions.

U.S. market

Roflumilast was approved by the FDA in the United States in 2011 for the treatment of COPD.

European market

Roflumilast has been approved in many European countries, including Germany, the United Kingdom and France. The wide acceptance in the European market proves the effectiveness and safety of the drug.

Asian market

Roflumilast has also been launched in many Asian countries and regions, including Hong Kong, Japan and South Korea. The launch in the Asian market further expands the drug's global reach.

The global marketing status of roflumilast reflects its important position in the treatment of COPD. As more countries and regions recognize the drug, patients will have easier access to this effective treatment.

The price of roflumilast

The price of roflumilast varies according to different regions and specifications. The following is the reference price of roflumilast in different regions.

Price of the German version of AstraZeneca in the UK

Roflumilast produced by AstraZeneca in the UK, the export specification for the German version is 500μg*30 tablets, and the reference price is about US$240 per box. The specification is 500μg*90 tablets, and the reference price is about US$400 per box. These prices may vary by pharmacy and purchase channel.

The price of the Hong Kong version of AstraZeneca in the UK

The Hong Kong version of Roflumilast produced by AstraZeneca in the UK is exported to 500μg*30 tablets, and the reference price is about US$140 per box. Prices in Hong Kong are relatively low and may be more suitable for patients with limited budgets.

Knowing the price of roflumilast can help patients make more informed decisions when choosing a treatment option. Price differences in different regions also provide patients with more choices.

By understanding where deroflumilast is available, available, and priced, patients can better plan how to obtain and use this drug.